Zhejiang Haizheng Pharmaceutical Co., Ltd. was established in 1956. In 2000, A shares were issued and listed as a state-controlled listed company. After more than 60 years of development, Haizheng Pharmaceutical has become a comprehensive pharmaceutical enterprise group integrating scientific research, production, marketing and vertical integration of raw materials and preparations.
As the first batch of innovative enterprises in China, Haizheng Pharmaceutical has a high-level and multi-dimensional R&D platform, and has established R&D centers in Taizhou headquarters, Shanghai, Hangzhou and the United States. It also has first-class R&D platforms, such as national enterprise technology center, the first batch of postdoctoral research centers, and Zhejiang Key Laboratory, which independently recruits postdoctoral qualifications in Zhejiang Province, and has the full chain capability of drug R&D..